Cargando…

Efficacy and Safety Profile of Risperidone Long-acting Injection in Adolescents in a Real-life Setting

OBJECTIVE: Risperidone long-acting injection (RLAI) was shown to be an alternative option in adult patients, but there is not available data in child and adolescents about this medication. The aim of this study is to evaluate the safety and efficiency profile of RLAI in a group of adolescents. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ardic, Ulku Akyol, Küçükköse, Mustafa, Inci, Sevim Berrin, Ercan, Eyüp Sabri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810445/ https://www.ncbi.nlm.nih.gov/pubmed/29397667 http://dx.doi.org/10.9758/cpn.2018.16.1.57

Ejemplares similares

Predicting aggression in children with ADHD
por: Ercan, Elif, et al.
Publicado: (2014)

Prevalence and diagnostic stability of ADHD and ODD in Turkish children: a 4-year longitudinal study
por: Ercan, Eyüp Sabri, et al.
Publicado: (2013)

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
por: Singh, Dhiren, et al.
Publicado: (2009)

Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia
por: Catalán, Rosa, et al.
Publicado: (2011)

Management of Persistent Hyponatremia Induced by Long-acting Injectable Risperidone Therapy
por: Chowdhury, Waliul, et al.
Publicado: (2018)

Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic
por: Chue, Pierre
Publicado: (2007)

Risperidone long-acting injection: a review of its long term safety and efficacy
por: Rainer, Michael K
Publicado: (2008)

Risperidone in the treatment of conduct disorder in preschool children without intellectual disability
por: Ercan, Eyup S, et al.
Publicado: (2011)

Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital
por: Nakamura, Yusuke, et al.
Publicado: (2019)

Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
por: Louzã, Mário Rodrigues, et al.
Publicado: (2011)

The cost associated with administering risperidone long-acting injections in the Australian community
por: Dalton, Andrew, et al.
Publicado: (2011)

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs, Larry, et al.
Publicado: (2013)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018)

Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety
por: Zhao, Mingjun, et al.
Publicado: (2023)

Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
por: El-Hage, Wissam, et al.
Publicado: (2010)

The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection
por: Stump, Trevor A., et al.
Publicado: (2021)

Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada
por: Lammers, Laura, et al.
Publicado: (2013)

Cumulative effects of risperidone long acting injection and narrative therapy in treating ethanol dependency
por: Trandafir, Maria Silvia
Publicado: (2010)

Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
por: Samalin, L, et al.
Publicado: (2010)

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
por: Zhao, Yueren, et al.
Publicado: (2013)

Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database
por: Voss, Erica A., et al.
Publicado: (2015)

Are the Long-Acting Intramuscular Formulations of Risperidone or Paliperidone Palmitate Associated with Post-Injection Delirium/Sedation Syndrome? An Assessment of Safety Databases
por: Alphs, Larry, et al.
Publicado: (2011)

Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone
por: Perlstein, Itay, et al.
Publicado: (2022)

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
por: Lambert, Tim, et al.
Publicado: (2011)

Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection
por: Asseburg, Christian, et al.
Publicado: (2012)

Successful Treatment of Anorexia Nervosa in a 10-year-old Boy with Risperidone Long-acting Injection
por: Umehara, Hidehiro, et al.
Publicado: (2014)

Use of therapeutic drug monitoring of risperidone microspheres long-acting injection in hemodialysis: A case report
por: Tourtellotte, Rebecca, et al.
Publicado: (2019)

Atomoxetine might be more effective in improving sluggish cognitive tempo symptoms after switching from methylphenidate: A case report
por: Tahıllıoğlu, Akın, et al.
Publicado: (2020)

Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
por: Olfson, Mark, et al.
Publicado: (2007)

E-mentoring program organized by the Turkish Association for Child and Adolescent Psychiatry during the COVID-19 pandemic
por: Ercan, Eyüp Sabri, et al.
Publicado: (2020)

Poly(Lactic Acid) Block Copolymers with Poly(Hexylene Succinate) as Microparticles for Long-Acting Injectables of Risperidone Drug
por: Chrysafi, Iouliana, et al.
Publicado: (2022)

Schizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study)
por: Giraud-Baro, Elisabeth, et al.
Publicado: (2016)

Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons
por: Ascher-Svanum, Haya, et al.
Publicado: (2012)

Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone
por: Baylé, Franck Jean, et al.
Publicado: (2015)

Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
por: Fabrazzo, Michele, et al.
Publicado: (2021)

In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey
por: Sarıgül Yıldırım, Figen, et al.
Publicado: (2022)

An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
por: Pandina, Gahan, et al.
Publicado: (2012)

Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
por: Dos Santos-Júnior, Amilton, et al.
Publicado: (2016)

Risperidone Related Raynaud’s Phenomenon: An Adolescent Case
por: Güneş, Serkan, et al.
Publicado: (2018)

Risperidone long-acting injection in the treatment of schizophrenia: 24-month results from the electronic Schizophrenia Treatment Adherence Registry in Canada
por: Williams, Richard, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bnuf2qmlf3moqu1prse7i3k2sr